English | 简体中文 | 繁體中文 | 한국어 | 日本語
Sunday, 20 September 2020, 13:13 HKT/SGT
Share:
Mitsubishi Chemical: Has developed new electrolyte for Tesla. The solvents and solute are supplied from Shida Shenghua

HONG KONG, Sept 20, 2020 - (ACN Newswire) - A Mitsubishi Chemical (MTLHY) technical expert revealed that the important innovations of Tesla's new battery are the positive and negative electrodes and the new electrolyte. Mitsubishi Chemical has perfectly matched the electrolyte technology for the new battery. This electrolyte mainly uses new solutes and functional additives, which can greatly improve battery performance. The technical expert said that the solvent in the new electrolyte is still supplied by the Chinese company Shida Shenghua, and the amount of DMC in the solvent will be greatly increased. Beginning in 2017, Mitsubishi and Shida Shenghua have jointly developed a new type of solute. This product will soon be mass-produced, which can effectively increase battery cycle times and energy density.


Topic: Press release summary Sectors: Daily Finance, Chemicals, Spec.Chem, Energy, Alternatives, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Isuzu and Toyota to Jointly Develop Japan's First Mass-produced Light-duty Fuel Cell Electric Truck  
Thursday, April 16, 2026 2:53:00 PM
Honda to Begin Sales of All-new Insight EV
  
Thursday, April 16, 2026 2:31:00 PM
3 Years and 11 Months! 'AI+All-in-One PV Storage' Sigenergy Listed on HKEX: Fastest IPO Record for a Chinese Enterprise  
Apr 16, 2026 11:31 HKT/SGT
GMG Doubles Energy Density of 6 Minute Charging Graphene Aluminium-Ion Battery  
Apr 15, 2026 19:59 HKT/SGT
Hitachi Energy and Samsung C&T expand strategic collaboration to accelerate grid infrastructure and reinforce energy security  
Wednesday, April 15, 2026 5:17:00 PM
Mitsubishi Motors' Outlander PHEV Ranks No. 1 in Japan's PHEV Sales Category for the Second Consecutive Year  
Wednesday, April 15, 2026 5:01:00 PM
OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies  
Apr 15, 2026 17:00 HKT/SGT
ASEAN Enterprises Move from AI Experiments to Engineering-Driven Deployment  
Apr 15, 2026 13:06 HKT/SGT
Exito Media Concepts Announces the 46th Edition of the Digital Transformation Summit Malaysia 2026  
Apr 15, 2026 11:05 HKT/SGT
DENSO Establishes Strategic Partnership with Oracle to Modernize Core Supply Chain Systems  
Wednesday, April 15, 2026 10:25:00 AM
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575